Inmed Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.42

+0.04 (+2.90%)

As of Sep 22, 6:05 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 38%

Sell 5 63%

Price Target

Analyst Price Target +2,269.7% upside

Low Target $24.21

Average Target $33.65

High Target $46.15

Current Price $1.42

Current
$1.42

Target
$33.65

$24.21 $33.65 avg $46.15

Scenario Analysis

Bear Case

$24.21

1,604.9%

Low target

Base Case

$33.65

+2,269.7%

Avg target

Bull Case

$46.15

+3,150.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.50

-43.2% from high

52-Week Low

$0.58

+147.0% from low

Target vs 52W High

$33.65

+1,246.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%